SCHEMBL6098733

SCHEMBL6098733

CO[C@@H]1O[C@H]([C@@H](C)OS(C)(=O)=O)[C@H]2OC(C)(C)O[C@@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17088022 0.86 — —
SCHEMBL800535 0.79 — —
SCHEMBL17087894 0.79 — —
SCHEMBL17087901 0.79 — —
SCHEMBL7150893 0.79 CYP3A4 (0.33) —
SCHEMBL7153212 0.79 CYP3A4 (0.33) —
SCHEMBL7150577 0.79 CYP3A4 (0.33) —
SCHEMBL7640958 0.79 CYP3A4 (0.33) —
SCHEMBL6099830 0.77 — —
SCHEMBL7149911 0.75 CA2 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7081449-B2 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides VALEANT RESEARCH & DEVELOPMENT (US) 2006-07-25 — — US disclosed
US-6831069-B2 Having substituents at the C4' and C5' positions of the ribofuranose moiety; anticancer and immunomodulating effects at reduced cytotoxicity; treating autoimmune diseases, cancer, dermatitis RIBAPHARM INC. 2004-12-14 — — US disclosed
EP-1303282-A4 PYRIDO[2,3-D]PYRIMIDINE AND PYRIMIDO[4,5-D]PYRIMIDINE NUCLEOSIDES RIBAPHARM INC (US) 2004-04-07 — — EP disclosed
EP-1363581-A2 PYRROLO(2,3-D)PYRIMIDINE NUCLEOSIDE ANALOGS Ribapharm, Inc. (US) 2003-11-26 — — EP disclosed
US-20030144502-A1 Pyrido[2,3-d]pyrimidine and pyrimido[4,5-d]pyrimidine nucleosides MDRNA RESEARCH, INC. 2003-07-31 — — US disclosed
EP-1303282-A1 PYRIDO[2,3-D]PYRIMIDINE AND PYRIMIDO[4,5-D]PYRIMIDINE NUCLEOSIDES Ribapharm, Inc. (US) 2003-04-23 — — EP disclosed
WO-2002100354-A2 PYRROLO[2,3-D]PYRIMIDINE NUCLEOSIDE ANALOGS RIBAPHARM INC. (US) 2002-12-19 — — WO disclosed
US-20020035077-A1 Pyrrolo[2,3-d]pyrimidine nucleoside analogs CEQUENT PHARMACEUTICALS, INC. 2002-03-21 — — US disclosed
WO-2002003997-A1 PYRIDO[2,3-D]PYRIMIDINE AND PYRIMIDO[4,5-D]PYRIMIDINE NUCLEOSIDES RIBAPHARM INC. (US) 2002-01-17 — — WO disclosed
Send feedback